BridgeBio Pharma announced yesterday the successful completion of the pivotal Phase 3 PROPEL 3 study evaluating Infigratinib. The data demonstrate...

Salesforce is undertaking a sweeping transformation, pruning roughly 1,000 roles across several divisions and revamping its leadership as it doubles...

Atreca, the biotechnology firm, is in the final phase of its wind-down and formal dissolution. Shareholders had already endorsed this...

Lynas Rare Earths Ltd. is experiencing a confluence of supportive factors, including rising commodity prices and increased geopolitical focus on...

Facing persistent softness in the traditional television advertising market, ProSiebenSat.1 Media is accelerating its transformation into a digital-focused group. The...

ServiceNow is implementing a strategic reshuffle within its financial leadership, designed to ensure continuity as the software giant aggressively pursues...

The bankruptcy proceedings for specialty retailer Conn's have entered their conclusive stage, sealing the fate of its equity holders. With...

While Eli Lilly continues to generate headlines and record earnings with its blockbuster weight-loss drugs, the pharmaceutical giant's leadership is...

A pivotal development for the Ethereum blockchain is set to commence, with the Ethereum Foundation scheduling its inaugural L1-zkEVM Breakout...

For investors in Coeur Mining, the immediate focus is shifting from daily market sentiment to two concrete catalysts: the imminent...